• 한국발생생물학회지:발생과생식
• /
• 제15권1호
• /
• pp.41-52
• /
• 2011

In the present study, embryoid bodies (EBs) obtained from induced pluripotent stem cells (iPSCs) were induced to differentiate into germ lineage cells by treatment with bone morphogenetic protein 4 (BMP4) and retinoic acid (RA). The results were compared to the results for embryonic stem cells (ESCs) and multipotent spermatogonial stem cells (mSSCs) and quantified using immunocytochemical analysis of germ cell-specific markers (integrin-${\alpha}6$, GFR-${\alpha}1$, CD90/Thy1), fluorescence activating cell sorting (FACS), and real time-RT-PCR. We show that the highest levels of germ cell marker-expressing cells were obtained from groups treated with 10 ng/$m{\ell}$ BMP4 or 0.01 ${\mu}M$ RA. In the BMP4-treated group, GFR-${\alpha}1$ and CD90/Thy-1 were highly expressed in the EBs of iPSCs and ESCs compared to EBs of mSSCs. The expression of Nanog was much lower in iPSCs compared to ESCs and mSSCs. In the RA treated group, the level of GFR-${\alpha}1$ and CD90/Thy-1 expression in the EBs of mSSCs Induced pluripotent stem cells, Mouse embryonic stem cells, Multipotent spermatogonial stem cells, Germ cell lineage, Differentiation potential. was much higher than the levels found in the EBs of iPSCs and similar to the levels found in the EBs of ESCs. FACS analysis using integrin-${\alpha}6$, GFR-${\alpha}1$, CD90/Thy1 and immunocytochemistry using GFR-${\alpha}1$ antibody showed similar gene expression results. Therefore our results show that iPSC has the potential to differentiate into germ cells and suggest that a protocol optimizing germ cell induction from iPSC should be developed because of their potential usefulness in clinical applications requiring patient-specific cells.

• 한국발생생물학회지:발생과생식
• /
• 제5권1호
• /
• pp.53-57
• /
• 2001

정자의 수정능력획득과 첨체반응은 Ca$^{2+}$에 의존적으로 일어나며, 수정능력획득 과정에서는 원형질막으로부터 cholesterol이 방출되어 첨체반응이 일어나기 쉬운 상태로 전환된다. 최근 세포막으로부터 cholesterol 방출을 촉진하는 methyl beta cyclodextrin (MBCD)이 첨체반응을 유발함이 알려졌으나 정자 주변의 Ca$^{2+}$ 농도와 관계없이 cholesterol 방출만으로 첨체반응이 유발되는지의 여부는 확인되지 않았다. 본 연구에서는 생쥐 정자에서 MBCD에 의한 첨체반응의 Ca$^{2+}$ 의존성을 조사하였다. 첨가된 Ca$^{2+}$이 없는 경우에도 MBCD는 농도 의존적으로 첨체반응을 증가시켰다. 저농도 (100 ${\mu}$M)의 Ca$^{2+}$의 존재시 MBCD에 의한 첨체반응이 유의하게 증가하였다. Ca$^{2+}$을 첨가하지 않은 배양액에 100 ${\mu}$M의 EGTA를 첨가한 경우 자발적 첨체반응을 유의하게 억제되었다. 같은 조건하에서 1 mM MBCD는 첨체반응을 유의하게 증가시켰으나 EGTA 비처리군보다 유의하게 낮아 MBCD에 의해 유발되는 첨체반응에 정자내부의 Ca$^{2+}$이 관여하는 것으로 사료된다. 이상의 결과에서 외부의 Ca$^{2+}$이 존재하지 않더라도 MBCD를 이용하여 첨체반응을 유발할 수 있으며 정자 내부의 Ca$^{2+}$이 원형질막 cholesterol의 방출에 따른 첨체반응 조절에 관여함을 알 수 있다.

• 한국식품저장유통학회지
• /
• 제19권5호
• /
• pp.792-798
• /
• 2012

신선초 추출물의 접촉성 아토피 피부염 완화효과를 확인하고 이의 소재를 개발하기 위한 목적으로 신선초 DW 추출물, 50% 에탄올 추출물, 100% 에탄올 추출물을 DNFB로 아토피를 유도한 마우스 동물모델에 각각 처리하여 in vivo 실험과 in vitro 실험을 실시하였다. 그 결과, 신선초 추출물을 처리한 군의 귀 손상정도가 대조군에 비해 감소되었으며, 귀 조직을 HE 염색으로 전체 귀 두께와 상피 두께를 측정하였을 때에도 대조군에 비해 상당한 감소를 나타냈다. 또한 RT-PCR로 염증 분자마커인 MMP series의 mRNA 발현수준을 검토한 결과, 신선초 추출물은 MMPs에 비의존적으로 마우스 아토피 피부염의 완화작용에 작용하는 것으로 나타났다. 마지막으로 염증반응을 유도한 마우스 비장조직세포에서 염증성 cytokine인 IL-4는 신선초 녹즙에서 농도 의존적으로 감소되었으며, IL-13 또한 신선초 녹즙과 에탄올 추출물에서 상당한 억제효과가 있음을 확인하였다. 이상의 결과로 신선초 추출물의 항아토피 활성을 확인 하였으며, 관련 제품 개발에 유용한 소재가 될 가능성을 확인하였다.

• Journal of Periodontal and Implant Science
• /
• 제28권2호
• /
• pp.235-247
• /
• 1998

Calcium sulfate has a long history of medical use as an implant material. The biocompatibiliry of the material has been clearly established. Bone ingrowth concomitant with resorption occurs rapidly with efficient conduction of bone from particle to particle. Calcium sulfate also has a potential for functioning as a good bamer membrane. The purpose of this study was to compare the biocompatibility of different types of calcium sulfate grafting materials including an expelimental calcium sulfate compound on periodontal ligament cells in vitro as a preliminary test towards the development of a more convenient and useful form of grafting material which could promote regeneration of periodontal tissue. Human periodontal ligament cells were collected from the premolar teeth extracted for orthodontic treatment. cells were cultured in a.MEM culture medium containing 20% FBS, at $37^{\circ}C$ and 100% humidity, in a 5% CO2 incubator. Cells were cultured into 96 well culture plate $1{\times}104$ cells per well with $\alpha$-MEM and incubated for 24 hours. After discarding the medium, those cells were cultured in $\alpha$-MEM contained with 10% FBS alone (control group), in medcal-grade calcium sulfate(MGCS group), in plaster(plaster group), experimental calcium sulfate paste(CS paste group) for 1, 2, 3 day respectively. And then each group was characterized by examining of the cell counting, MTI assay, collagen synthesis. The results \vere as follows. 1. In the analysis of cell proliferation by cell counting, both medical-grdde calcium sulfate group and plaster group showed no stastically significant difference at day 1, 2, 3 accept for plaster group at day 1 compared to control group, but there was stastically significant difference between CS paste group and all other groups at day 1, 2, 3(P<0.05). 2. In the analysis of cytotoxicity by MIT assay, both medical-grade calcium sJlfate group and plaster group showed no stastically significant difference compared to control group at day 1, 2, 3 but there was stastically significant difference between CS paste group and all other groups at day 1, 2, 3(P<0.OS). 3. In the analysis of collagen synthesis by immunoblotting assay, high level was detected for medical-grade calcium sulfate group and plaster group at day 1, 2, 3 compared to CS paste group. On the basis of these results, medical-grade calcium sulfate and plaster was shown to possess biocompatibility whereas the CS paste had unfavourable outcome. This observation shows a need for modification of the materials contained in calcium sulfate paste.

• Journal of Periodontal and Implant Science
• /
• 제31권2호
• /
• pp.401-420
• /
• 2001

A novel glucanhydrolase from a mutant of Lipomyces starkeyi(KSM 22)has been shown effective in hydrolysis of mutan, reduction of mutan formation by Streptococcus mutans and removal pre-formed sucrose-dependent adherent microbial film and Lipomyces starkeyi KSM 22 dextranase has been strongly bound to hydroxyapatitie. These in vitro properties of Lipomyces starkeyi KSM 22 dextranase are desirable for its application as a dental plaque control agent. This study was performed to determine oral hygiene benefits and safety of dextranase(Lipomyces starkeyi KSM 22 dextranase)-containing mouthwash in human experimental gingivitis. This 3-week clinical trial was placebo-controlled double-blind design evaluating 1U/ml dextranase mouthwash and 0.12% chlorhexidine mouthwash. A total 39 systemically healthy subjects, who had moderate levels of plaque and gingivitis were included. At baseline, 1, 2 and 3 weeks, subjects were scored for plaque(Silness and $L{\ddot{o}e$ plaque index and plaque severity index), gingivitis($L{\ddot{o}e$ and Silness gingival index), and at baseline and 3 weeks of experiment, subjects were scored for plaque(Turesky-Quingley-Hein's plaque index and plaque severity index), tooth stain(Area and severity index system by Lang et al). Additionally, oral mucosal examinations were performed and subjects questioned for adverse symptoms. Two weeks after pre-experiment examinations and a professional prophylaxis, the subjects provided with allocated mousewash and instructed to use 20-ml volumes for 30s twice dailywithout toothbrushing. All the groups showed significant increase in plaque accumulation since 1 week of experiment. During 3 weeks' period, the dextranase group showed the least increase in plaque accumulation of Silness and $L{\ddot{o}e$ plaque index, compared to the chlorhexidine and placebo groups, but chlorhexidine group showed the least increase inplaque accumulation of Turesky-Quingley-Hein's plaque index. As for gingival inflammation, all the groups showed significant increase during 3 weeks of experiment. The dextranase group also showed the least increase in gingival index score, compared to the chlorhexidine as well as the placebo groups. Whereas the tooth stain was increased significantly in the chlorhexidine group, compared to the baseline score and the placebo group since 3 weeks of mouthrinsing. It was significantly increased after 3 weeks in the dextranase group, still less severe than the chlorhexidine group. As for the oral side effect, the dextranase group showed less tongue accumulation, bad taste, compared to the chlorhexidine group. From these results, mouthrinsing with Lipomyces starkeyi KSM 22 dextranase was comparable to 0.12% chlorhexidine mouthwashin inhibition of plaque accumulation and gingival inflammation and local side effects were if anything less frequent and less intense than chlorhexidine, in human experimental gingivitis. All data had provided positive evidence for Lipomyces starkeyi KSM 22 dextranase as an antiplaque agent and suggested that further development of dextranase formulations for plaque control are warranted.

• 생명과학회지
• /
• 제17권11호
• /
• pp.1492-1496
• /
• 2007

CD40L를 발현하는 KU812세포와 CD40를 발현하는 항원 특이적 B 세포의 배양을 통해 IgE 클라스 스위치가 유도된다. 본 연구자는 체외면역법에 의해 건강인의 말초혈액을 이용하여 쌀 알레르겐 특이적 IgM 항체를 생성하는 B 세포주를 수립하였다. 본 연구에서는 KU812세포에 의한 쌀 알레르겐 특이적 IgE 항체의 유도를 시도하였다. 배양 전, 쌀 알레르겐 특이적 B 세포주, RA9G11과 PMA와 ionomycin을 6시간 처리하여 활성화된 KU812세포에서 CD40와 CD40L 발현량을 flow cytomerty를 통화여 각각 확인하였다. RA9G11세포와 활성화된 KU812세포는 높은 수준의 CD40와 CD40L를 각각 발현하였다. 쌀 알레르겐 특이적 IgE항체 합성 유도를 위해, 여러 가지 농도의 IL-4 존재하에, RA9G11세포와 활성화된 KU812세포를 12일 동안 배양하였다. IgE 정상영역의 mRNA 발현량과, 쌀 알레르겐 특이적 IgE 항체 생성 세포가 모든 조건에서 확인되었으며, 특히 50U의 L-4 농도 하에서 같은 비율의 RA9G11과 활성화된 KU812세포를 배양했을 때, IgE 합성이 가장 높았다. 따라서 활성화된 KU812세포에 의한 쌀 알레르겐 특이적 IgE 합성은 알레르기 질환의 치료 및 예방에 관한 연구에 기여할 것으로 사료된다.

• 생명과학회지
• /
• 제33권6호
• /
• pp.512-522
• /
• 2023

전세계적으로 인류를 위협하는 가장 큰 질병은 악성종양 혹은 암이다. 이에 따라, 수술적 요법, 항암제를 사용한 항암 요법, 방사선 요법, 면역 요법을 포함한 여러 다양한 방법이 다양한 암의 진단과 치료를 위해 단독 혹은 혼용하여 현재까지 적용되고 있으나, 지금까지 가장 흔히 적용되는 항암 요법은 심각한 부작용이나 특정한 암에 제한적으로 적용되기도 하는 문제점을 가지고 있어, 좀 더 부작용이 낮은 새로운 치료 방법이 절실한 실정이다. 일반적으로 무한 증식을 하는 줄기세포는 세포 분화 후 세포의 성장이 정지되는 것으로 알려져 있다. 이에 이 총설에서는 거의 모든 암세포에서 공통적으로 나타나는 높은 포도당 대사 과정을 가진 암세포에 지방세포로의 분화를 유도하여, 분화된 암세포가 성장 억제 효과가 일어날 수 있는지 조사하였다. 여러 선행 연구에서, 당뇨병의 치료제로 사용되는 TDZs 계열의 약물을 여러 조직 기원의 암세포에 체외 투여하였을 때, 많은 조직 기원의 암세포주는 지방세포로 분화가 되는 것으로 알려줬으며, 분화된 암세포주는 세포의 성장이 점점 억제되는 것을 알 수 있었다. 이러한 결과들을 종합해 볼 때, 거의 모든 암세포에서 공통적으로 나타내는 높은 포도당 대사를 이용하여, 암세포를 지방세포로 분화를 유도하는 방법으로 암의 치료를 위한 한 요법 혹은 보조 요법으로 적용이 가능할 것으로 생각된다. 그러나, 체내에서 임상적으로 적용을 위해서는 지방세포 분화를 위한 약물이 성상 체세포 및 우리 몸의 재생을 위해 존재하는 줄기세포에 미치는 영향과 여러 체내 부작용을 면밀하게 조사하는 것이 필요할 것으로 생각된다.

• 한국수정란이식학회지
• /
• 제24권3호
• /
• pp.199-205
• /
• 2009

This study was carried out to investigate the effective genetic resources preservation system using the frozen boar semen. The porcine oocytes were matured for 44 hours in NCSU-23 medium with or without 10% Porcine Follicle Fluid (PFF), 0.5 ${\mu}g/ml$ porcine FSH, 0.5 ${\mu}g/ml$ equine LH, 1.0 ${\mu}g/ml$ 17 $\beta$-estradiol ($E_2$) and 10 ng/ml Epidermal Growth Factor (EGF) under mineral oil at $38.5^{\circ}C$ in humidified atmosphere of 5% $CO_2$ in air. After 44 h of culture, the oocytes were inseminated with frozen-thawed semen and fresh semen prepared with mTBM medium for 6 h. Later, set of 50 presumptive zygotes were transferred into 4-well dish (500 ${\mu}l$) of IVC medium. for embryos freezing, slow-freezing and vitrification methods were used as a cryopreservation. Differences among treatments were analyzed using General Linear Model Procedure by SAS Package (version 6.12) differences were considered significant when p<0.05. Following IVF and IVC, the rates of cleavage and blastocysts formation were significantly higher (p<0.05) in hormone supplemented group than that of hormone-free group (25.7 vs, 12.1). The development rates to cleavage and blastocysts were significantly higher in PZM-5 group than NCSU-23 group (60.3%, 46.6% vs 27.4%, 11.1%). Further improvement was achieved when PZM-5 was supplemented with FBS. Cleavage rates was significantly higher in fresh semen source group than frozen semen (66.7% vs 43.7%). However in blastocysts rates was similar two groups. Post-thaw survival rates of embryos were 1.2% and 2.2% in slow-frezing and vitrification groups, respectively. The results of our study suggest that it is still possible to improve the culture conditions and boar semen cryopreservation for enhance reproductive technology and animal genetic resources conservation.

• 동의생리병리학회지
• /
• 제25권6호
• /
• pp.1061-1068
• /
• 2011

Moxibustion is a treatment method for cold and pain in Korean medicine. But the systematic study of moxibustion were very few. This study was aimed to survey and evaluate moxibustion study in Korean medicine. We search the moxibustion study in journals related Korean medicine and http://oasis.kiom.re.kr. The period of the study from first issue to August, 2010. The search word were moxibustion, moxa in keyword and moxibustion treatment in title. We totally search 334 articles. But 175 articles were excluded because this study were not exactly moxibustion study, so we included and analyzed 159 articles. The study of moxibustion were 159 articles. Literature review were 35 articles, systematic review 8, heat experiment 10, in vivo or vitro 28 and survey investigation 3. Clinical articles of moxibustion related to Korean medical journals were 76. Before and after study were 31 articles, case report 20, cohort study 7, cross-sectional study 2, nonrandomized study 6, quasi randomized study 1, randomized clinical trials 9. This results showed that moxibustion study were smaller than acupuncture or herb and concentrated to pain and cold syndrome. We need further larger and diverse study of moxibustion.

• 생명과학회지
• /
• 제28권7호
• /
• pp.827-834
• /
• 2018

본 연구는 유용 미생물을 이용하여 흰점박이 꽃무지 유충을 발효시킨 분말을 수용성, 에탄올, 메탄올 용매별 추출하여 항산화 등의 실험에 임하였다. 발효 균주로는 3종의 유산균 Lactobacillus plantarum JBMI F3, Lactobacillus plantarum JBMI F5, Lactobacullus gasseri Ba9, 1종의 곰팡이 Aspergillus kawachii KCCM 32819, 1종의 효모 Saccharomyces cerevisiae KACC 93023, 1 종의 바실러스 Bacillus subtilis KACC 91157 총 6종의 유용 미생물 균주를 사용하였다. 발효 굼벵이 분말 추출물의 유효성분(총 페놀 함량 및 플라보노이드 함량)과 생리 활성 효능(DPPH 자유 라디칼 소거 활성, 환원력 실험, 혈전용해능, ${\alpha}-amylase$ 활성)을 비교 검토하였다. 총 페놀 함량 및 플라보노이드 함량은 바실러스 균주 발효 굼벵이 분말의 수용성 추출물에서 높은 수치를 나타내었다. 항산화 활성을 확인하기 위해 DPPH 자유 라디칼 소거능 및 환원력 실험을 수행한 결과, 비발효군 보다 발효군에서 우수한 항산화능을 보였고, 그 중 바실러스 균주를 이용한 발효 추출물이 긍정적인 효과를 나타내었다. 혈전 용해능에서 또한, 바실러스 균주 발효 굼벵이 추출물에서 우수한 혈전 용해능을 확인였고, 효소-기질 분해능 실험의 ${\alpha}-amylase$ 활성은 비발효군보다 발효군에서 높은 효과를 확인하였으나 발효균주간 유의적인 차이는 없었다. 따라서, 유용 미생물을 이용한 발효 굼벵이 추출물의 유용성분 및 생리활성이 강화됨을 확인하였고, 이는 건강 식품 소재로의 이용 가능성이 높다고 판단된다.